Le Lézard
Classified in: Health, Science and technology
Subjects: CCA, FVT

Akero Therapeutics to Present at the Jefferies 2019 London Healthcare Conference


SAN FRANCISCO, Nov. 13, 2019 /PRNewswire/ -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage biotechnology company developing transformational treatments for patients with non-alcoholic steatohepatitis (NASH) and other serious metabolic disorders, today announced that members of the management team will provide a business overview and update at the Jefferies 2019 London Healthcare Conference at 8:00 a.m. GMT on Wednesday, November 20, 2019.

A live webcast of the presentation will be available through the investor relations section of the Company's website at www.akerotx.com. Following the live webcast, an archived replay will be available on the Company's website.

About Akero Therapeutics
Akero Therapeutics is a clinical-stage biotechnology company focused on the development and commercialization of transformative treatments for patients with NASH and other serious metabolic diseases with high unmet medical need. The Company's lead program AKR-001 is being evaluated in a Phase 2a clinical trial for the treatment of NASH. AKR-001 is an engineered human Fc-FGF21 fusion protein designed to harness the inherent benefits of an endogenous hormone called FGF21, with the potential to reduce liver fat, mitigate inflammation, and reverse fibrosis in NASH patients. Akero Therapeutics is headquartered in San Francisco, CA. For more information, please visit www.akerotx.com.

 

(PRNewsfoto/Akero Therapeutics, Inc.)

 

SOURCE Akero Therapeutics, Inc.


These press releases may also interest you

at 17:35
Aviitm (www.avii.com), provider of the Avii Workspacetm unified SaaS platform for tax, audit, advisory, compliance and management consulting firms, predicts the 2020 tax season will further expose the growing chasm between ever increasing challenges...

at 17:35
Today it was announced that Insurmi, a conversational-AI powered customer engagement platform for insurance carriers, was one of just 10 promising early stage companies to be named a winner in the highly competitive Arizona Innovation Challenge...

at 17:30
SQI Diagnostics Inc. ("SQI" or the "Company") , today reported its financial and operational results for the fourth quarter and fiscal year ended September 30, 2019. SQI is a Toronto-based life sciences and diagnostics company that develops and...

at 17:30
Visual Communications Company (VCC), a recognized global leader in the illuminated electronics market, is proud to win its second consecutive Elektra Award for the VentoFlex lighting system. For 17 years, the Elektra Awards have acknowledged...

at 17:28
Audacious Inquiry (Ai), an industry leader in connected care, was awarded a new contract to expand the PULSE platform to improve usability, scalability, and flexibility to support a tighter integration with the national data exchange frameworks....

at 17:25
In its support of the EBR Law Enforcement Agencies, General Informatics is donating its state-of-the-art Realtime Crime Management Platform - 365 RealTimetm software, free of cost to the City of Baton Rouge and the East Baton Rouge Parish. General...



News published on 13 november 2019 at 16:01 and distributed by: